Bill Commons

NY A 8850

in committee

Relates to circumstances under which a consumer may be subject to a new special open enrollment period to choose a new health insurance plan

New York · 2025-2026 Regular Session · lower

Quick answers

Did NY A 8850 pass?

Not yet. NY A 8850 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO INSURANCE

What is NY A 8850 about?

Allows for a new special open enrollment period to choose a new health insurance plan for consumers in certain instances to allow for continuity of care with an existing health care provider.

Who sponsors NY A 8850?

Gabriella Romero is the primary sponsor of NY A 8850, joined by 4 cosponsors.

Description

Allows for a new special open enrollment period to choose a new health insurance plan for consumers in certain instances to allow for continuity of care with an existing health care provider.

Introduced
—
Latest action
2026-01-07 — REFERRED TO INSURANCE
Bill type
bill
Last updated
—

Sponsors

  • Gabriella Romeroprimary
  • Phil Steckcosponsor
  • Judy Griffincosponsor
  • Mike Reillycosponsor
  • Emerita Torrescosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-06-09

    REFERRED TO INSURANCE

    referral-committee

  2. 2026-01-07

    REFERRED TO INSURANCE

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 8850. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.